Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 5, 2023
HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous TumorsMarie C Smithgall, Anna Yemelyanova, Susan Mathew, et al.
Plos One|April 2, 2015
Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinomaDenise R Minton, Leiping Fu, Qiuying Chen, et al.
Archives of Pathology & Laboratory Medicine|June 2, 2015
Multiphoton microscopy: a potential intraoperative tool for the detection of carcinoma in situ in human bladderManu Jain, Brian D Robinson, Maria M Shevchuk, et al.
Anticancer Research|December 11, 2013
Expression of cyclin d1 and its association with disease characteristics in bladder cancerPradeep Kumar Kopparapu, Stephen A Boorjian, Brian D Robinson, et al.
Cancer Cytopathology|June 22, 2018
Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomasPatrick J McIntire, Justin T Snow, Brian D Robinson, et al.
Anticancer Research|June 11, 2013
Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancerPradeep Kumar Kopparapu, Stephen A Boorjian, Brian D Robinson, et al.
European Urology Focus|July 11, 2021
Clipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesSpyridon P Basourakos, Alec Zhu, Patrick J Lewicki, et al.
European Urology Oncology|September 8, 2019
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysisShokhi Goel, Jonathan E Shoag, Michael D Gross, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
SPOP mutations in prostate cancer across demographically diverse patient cohortsMirjam Blattner, Daniel J Lee, Catherine O'Reilly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Pageof 20